(Q39032987)

30 June 2019

review article

1 reference

title

Antibiotics for the neurological complications of Lyme disease (English)

1 reference

30 June 2019

0 references

Diego Cadavid

1

1 reference

30 June 2019

Paul G Auwaerter

series ordinal

2

1 reference

30 June 2019

Jeffrey Rumbaugh

series ordinal

3

1 reference

30 June 2019

Harald Gelderblom

series ordinal

4

1 reference

30 June 2019

publication date

8 December 2016

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

volume

12

1 reference

30 June 2019

page(s)

CD006978

1 reference

30 June 2019

Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children--a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

A comparison of two treatment regimens of ceftriaxone in late Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Cefotaxime versus penicillin in the late stage of Lyme disease--prospective, randomized therapeutic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Lyme disease-a tick-borne spirochetosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis - a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Western blotting in the serodiagnosis of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

21 January 2018

Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Lyme neuroborreliosis-epidemiology, diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Treatment for the neurological complications of Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD006978.PUB2

Evaluation of study patients with Lyme disease, 10-20-year follow-up.

21 January 2018

1 reference

12 December 2020

Treatment of early lyme disease

1 reference

12 December 2020

Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G

1 reference

12 December 2020

Clinical manifestations and diagnosis of neuroborreliosis

1 reference

12 December 2020

Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

1 reference

12 December 2020

Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis

1 reference

12 December 2020

Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease

1 reference

12 December 2020

Evaluation of the intrathecal antibody response to Borrelia burgdorferi as a diagnostic test for Lyme neuroborreliosis

1 reference

12 December 2020

Successful treatment of erythema migrans Afzelius

1 reference

12 December 2020

Nervous system Lyme disease

1 reference

12 December 2020

10.1002/14651858.CD006978.PUB2

Identifiers

DOI

1 reference

30 June 2019

PMCID

6463975

1 reference

30 June 2019

PubMed ID

27931077

1 reference

30 June 2019